Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS
December 22, 2022Medical Communications
Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …
AstraZeneca shares two new drug approvals in the EU
December 22, 2022Medical Communications
On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …
Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug
December 22, 2022Medical Communications
Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …
New monoclonal antibody for hospitalised COVID-19 patients approved by FDA
December 22, 2022Medical Communications
The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …
Abiomed receives FDA approval for heart pump clinical trial
December 22, 2022Research and Development
Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …
OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas
December 22, 2022Business Services
Nantes, France – December 22,
Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery
December 21, 2022Medical Communications
LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …
Kite set to acquire Tmunity Therapeutics
December 21, 2022Medical Communications
Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …
Two biotech CEOs charged with defrauding investors over investigational HIV drug
December 21, 2022Medical Communications
Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …
Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths
December 21, 2022Medical Communications
A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …
Tamiflu manufacturers report shortages during high point of flu season
December 21, 2022Medical Communications
The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …
Sosei Heptares’ Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
December 21, 2022Business Services
Tokyo, Japan and Cambridge, UK, 21 December 2022 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of Artificial Intelligence Programme
December 21, 2022Business Services
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical company, announces that it …
NICE EXTENDS USE OF ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) TO EARLIER IN THE TREATMENT OF HER2 POSITIVE METASTATIC BREAST CANCER
December 20, 2022Business Services
Uxbridge and London, UK – (20 December 2022) – Daiichi Sankyo UK Limited and AstraZeneca UK Limited today welcome the …
Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension
December 20, 2022Research and Development
Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …
AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s
December 20, 2022Research and Development
AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …
ServBlock secures EU funding for pharma manufacturing data space
December 20, 2022Medical Communications
ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system …
Abbott’s Eterna spinal cord stimulation system given FDA approval
December 20, 2022Medical Communications
US-based Abbott Laboratories has announced that their Eterna spinal cord stimulation (SCS) system has been given approval by the FDA. …
Unison boss states Government has “adamantly refused” to engage in a “proper discussion” on pay ahead of Wednesday’s ambulance strikes
December 19, 2022Medical Communications
Unison general secretary Christina McAnea has said that Wednesday’s ambulance strikes will go ahead without a “very firm commitment” on …
FDA approves first gene therapy to treat patients with high-risk, non-muscle-invasive bladder cancer
December 19, 2022Medical Communications
The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive …
Latest content
FibroFind appoints Lee Borthwick as CEO
